Literature DB >> 30876788

Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.

Chen-Ta Chi1, Gar-Yang Chau2, Rheun-Chuan Lee3, Yen-Ying Chen4, Hao-Jan Lei2, Ming-Chih Hou1, Yee Chao5, Yi-Hsiang Huang6.   

Abstract

BACKGROUND/
PURPOSE: Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare primary liver cancer. Preoperative diagnosis of cHCC-CCA is difficult, and outcome of cHCC-CCA is obscured. Our study aimed to investigate the clinicopathological and radiological features of cHCC-CCA and compare their outcomes with hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).
METHODS: From August 2010 to December 2017, 891 patients undergoing liver tumor resection in Taipei Veterans General Hospital, including 30 patients with pathology-proven cHCC-CCA, 819 HCC, and 42 ICC were retrospectively reviewed. Radiological features of contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI) in patients with cHCC-CCA were reevaluated by a radiologist. Factors association with disease-free survival (DFS) and overall survival (OS) were analyzed.
RESULTS: The mean age of cHCC-CCA, HCC and ICC was similar. Hepatitis B virus infection was prevalent in patients with cHCC-CCA (22/30, 73.3%). Most (70%) of the cHCC-CCA had atypical radiological pattern of HCC and belonged to classic type in pathological features. cHCC-CCA and ICC had worse DFS, but the 5-year OS of cHCC-CCA was substantial adequate after surgery. Of the 891 patients, male gender, advanced T stage, multiple tumor number, alpha-fetoprotein (AFP) level >20 ng/ml, cHCC-CCA, and ICC were factors associated with poor DFS in multivariable analysis. Older age, T stage 3 or 4, presence of macrovascular invasion, AFP >20 ng/mL, cHCC-CCA, and ICC were factors significantly associated with OS.
CONCLUSION: cHCC-CCA is associated with high risk of recurrence following surgical resection as compared with HCC. Closely post-operative monitoring is highly recommended.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  HCC; ICC; Recurrence; Survival; cHCC-CCA

Mesh:

Substances:

Year:  2019        PMID: 30876788     DOI: 10.1016/j.jfma.2019.02.012

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  3 in total

1.  Progress toward improving outcomes in patients with cholangiocarcinoma.

Authors:  Hiroko Kawasaki; Yuko Akazawa; Nataliya Razumilava
Journal:  Curr Treat Options Gastroenterol       Date:  2021-01-30

2.  Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma.

Authors:  You-Yin Tang; Yu-Nuo Zhao; Tao Zhang; Zhe-Yu Chen; Xue-Lei Ma
Journal:  World J Gastroenterol       Date:  2021-11-07       Impact factor: 5.742

3.  Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection.

Authors:  Pinxiong Li; Lei Wu; Zhenhui Li; Jiao Li; Weitao Ye; Zhenwei Shi; Zeyan Xu; Chao Zhu; Huifen Ye; Zaiyi Liu; Changhong Liang
Journal:  Front Oncol       Date:  2021-08-13       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.